Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
November 15, 2024Harry Paul Erba, MD, PhD - New Tools, New Considerations: Optimizing Our Approaches to Managing Newly Diagnosed FLT3-Mutant AML20 minutesPlayHarry Paul Erba, MD, PhD - New Tools, New Considerations: Optimizing Our Approaches to Managing Newly Diagnosed FLT3-Mutant AML...moreShareView all episodesBy PeerVoice4.844 ratingsNovember 15, 2024Harry Paul Erba, MD, PhD - New Tools, New Considerations: Optimizing Our Approaches to Managing Newly Diagnosed FLT3-Mutant AML20 minutesPlayHarry Paul Erba, MD, PhD - New Tools, New Considerations: Optimizing Our Approaches to Managing Newly Diagnosed FLT3-Mutant AML...moreMore shows like PeerVoice Internal Medicine AudioView allPeerVoice Oncology & Haematology Audio1 ListenersPeerVoice Heart & Lung Video0 ListenersPeerVoice Endocrinology & Metabolic Disorders Audio7 ListenersPeerVoice Endocrinology & Metabolic Disorders Video2 ListenersPeerVoice Digestive Diseases Audio0 ListenersPeerVoice Digestive Diseases Video0 ListenersPeerVoice Immunology & Infectious Disease Video0 ListenersPeerVoice Immunology & Infectious Disease Audio1 ListenersPeerVoice Internal Medicine Video0 ListenersJAMA Clinical Reviews496 ListenersCore IM | Internal Medicine Podcast1,095 ListenersAnnals On Call Podcast185 ListenersThe Clinical Problem Solvers519 ListenersRun the List248 ListenersMayo Clinic Center for Sleep Medicine3 Listeners
Harry Paul Erba, MD, PhD - New Tools, New Considerations: Optimizing Our Approaches to Managing Newly Diagnosed FLT3-Mutant AML
November 15, 2024Harry Paul Erba, MD, PhD - New Tools, New Considerations: Optimizing Our Approaches to Managing Newly Diagnosed FLT3-Mutant AML20 minutesPlayHarry Paul Erba, MD, PhD - New Tools, New Considerations: Optimizing Our Approaches to Managing Newly Diagnosed FLT3-Mutant AML...more
Harry Paul Erba, MD, PhD - New Tools, New Considerations: Optimizing Our Approaches to Managing Newly Diagnosed FLT3-Mutant AML